EVAHF (EGF Theramed Health) EBIT per Share: $-0.01 (TTM As of Mar. 2026)


What is EGF Theramed Health EBIT per Share?

EGF Theramed Health EVAHF EBIT per Share is $-0.01 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 529 Healthcare Providers & Services companies, EGF Theramed Health ranks better than 92.44% on this metric.

EGF Theramed Health's EBIT per Share for the three months ended in Mar. 2026 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 62.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 65.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was 55.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for EGF Theramed Health's EBIT per Share or its related term are showing as below:

EVAHF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -178.1   Med: 31.4   Max: 89.2
Current: 62.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of EGF Theramed Health was 89.20% per year. The lowest was -178.10% per year. And the median was 31.40% per year.

EVAHF's 3-Year EBIT Growth Rate is ranked better than
92.44% of 529 companies
in the Healthcare Providers & Services industry
Industry Median: 11.8 vs EVAHF: 62.60

EGF Theramed Health's EBIT for the three months ended in Mar. 2026 was $-0.06 Mil.


EGF Theramed Health  (OTCPK:EVAHF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


EGF Theramed Health EBIT per Share Related Terms


EGF Theramed Health EBIT per Share Historical Data

* Premium members only.

The historical data trend for EGF Theramed Health's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EGF Theramed Health EBIT per Share Chart

EGF Theramed Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.49 -0.05 -0.02 -0.01

EGF Theramed Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.01 -0.00 -0.00 -0.01

EGF Theramed Health EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

EGF Theramed Health's EBIT per Share for the fiscal year that ended in Jun. 2025 is calculated as

EBIT per Share(A: Jun. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.153/11.596
=-0.01

EGF Theramed Health's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.061/11.617
=-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.01 mean?
EGF Theramed Health (EVAHF) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EGF Theramed Health and its competitors. According to the industry distribution chart, EGF Theramed Health ranks #40 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 7.6%.
Is EGF Theramed Health's EBIT per Share too high?
EGF Theramed Health's current EBIT per Share is $-0.01. Based on the distribution chart, EGF Theramed Health ranks #40 out of 529 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does EGF Theramed Health's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EGF Theramed Health ranks #40 out of 529 companies for EBIT per Share. This places EGF Theramed Health in the top 8% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EGF Theramed Health and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EGF Theramed Health's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EGF Theramed Health stock overvalued right now?
EGF Theramed Health (EVAHF) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For EGF Theramed Health (EVAHF), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EGF Theramed Health Business Description

Other Exchanges AUH:GermanyTMED:Canada
Address 609 Granville Street, Suite 1600, P.O. Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. It explores many other medical areas including weight loss, skincare and heart disease.